🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Salman R. Punekar

Columbia University Irving Medical Center

ORCID: 0000-0002-7613-6305

Also affiliated with NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study”.

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012
N/A
0.571DataRank · unranked
44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy

Cancer Research(2025)10.1158/0008-5472.can-25-0998
N/A
0.104DataRank · unranked
1 citations

Soumyadip Sahu, Minjie Zhang, Ayushi S. Patel, Ke Geng, Reshmee Bhattacharya +47 more

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.10.516003
N/A
0DataRank · unranked
3 citations

Hua Zhou, Nina Shenker-Tauris, Hortense Le, Theodore Sakellaropoulos, Nicolas Coudray +32 more

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-42327-x
N/A
0DataRank · unranked
29 citations

Hua Zhou, Nina Murrell, Hortense Le, Theodore Sakellaropoulos, Nicolas Coudray +35 more

In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.18.537350
N/A
0DataRank · unranked
1 citations

David H. Peng, David Fenyö, Hao Yuan, Alfonso Lopez, Daniel Levin +26 more

6MO: Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology(2025)10.1016/s1556-0864(25)00201-1
N/A
0DataRank · unranked
16 citations

Dehan Hong, Jia Luo, S-H.I. Ou, M.L. Johnson, A.I. Spira +10 more